© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism. However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators. Comparing their expectations to the market could help investors estimate their prospective return.
Period
High
Low
Performance
1 Week1 MonthQuarterHalf Year1 YearYTD9.29.29.216.31749.24.074.073.53.53.54+24.59%+25.76%-7.09%-62.37%-84.09%+32.59%BDRX has a current P/E ratio of 0
The BDRX stock has a trailing twelve month price-to sales (P/S) ratio of 0.07 while its price-to-book (P/B) value is 0.
BDRX's price-to-free-cashflow (P/FCF) ratio is 0, an indicator that is currently being trending upward.
Based on BDRX's recent bid, its distance from 20 days simple moving average is 23.94%. It is 19.84% apart from 50 days simple moving average, and it is -59.64% apart from 200 days simple moving average.
The 52-week high for BDRX is $74.00 which is -92.74% away from the current price level whereas the distance of that from the 52-week low of $3.50 stands at 53.43%.
The performance of BDRX stock was not encouraging with most of its significant price indicators in green. Biodexa Pharmaceuticals Plc(NASDAQ: BDRX) shares have moved upward +31.94% or $1.30 in the latest trading session and have gained 32.59% year-to-date (YTD). The stock has lost nearly -84.09% over the past year. After moving -7.09% over the trailing 3-month period, the stock is -62.37% lower in the 6-month period. Looking at its performance over the shorter term, it'sgained 24.59% a week and 25.76% a month.
The current 14-day RSI for BDRX stock is 67.3. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Biodexa Pharmaceuticals Plc (BDRX) has a 14-day ATR of 0.61.
After closing at $4.07 with 580.84K of its shares outstanding, the current enterprise value of BDRX is roughly -.
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) is down -84.09% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 20.69%. BDRX stock price is also up 32.59% on its value in year-to-date trading.
The number outstanding shares of BDRX is 580.84K, and of these 365,728.43% shares are freely available for trading. On average, BDRX stock has traded 4.36M shares per day for the past 10 days. A total of 21.89M shares changed hands during the last trading session with the average session volume of 138.74K shares.